Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
Rheumatology (Oxford, England)|October 19, 2017
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder indexKenneth C Kalunian, Murray B Urowitz, David Isenberg, et al.
Arthritis and Rheumatism|August 1, 2007
Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosusKathleen McElhone, Janice Abbott, Joanna Shelmerdine, et al.
Arthritis and Rheumatism|July 9, 2011
Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasisAnastasia Lambrianides, Tabitha Turner-Stokes, Charis Pericleous, et al.
The Journal of Rheumatology|September 3, 2010
The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosusKathleen McElhone, Madhura Castelino, Janice Abbott, et al.
Rheumatology (Oxford, England)|November 30, 2014
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroidsFowzia Ibrahim, Ernest Choy, Patrick Gordon, et al.
The Journal of Rheumatology|May 23, 2002
The rate and pattern of organ damage in late onset systemic lupus erythematosusPeter Maddison, Vernon Farewell, David Isenberg, et al.
Rheumatology (Oxford, England)|December 19, 2024
Improving the arthritis component of the SLEDAI-2KKhaled Mahmoud, Md Yuzaiful Md Yusof, Lee Suan Teh, et al.
Autoimmunity Reviews|October 29, 2011
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohortsCándido Díaz-Lagares, Sara Croca, Shirish Sangle, et al.
Rheumatology (Oxford, England)|January 19, 2010
The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLEBridget Griffiths, Paul Emery, Vicky Ryan, et al.
Pageof 16